The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy

Journal of Urology

Volumn 156, Issue 5, 1996, Pages 1725-1729

  Schild, Steven E ^a   Buskirk, Steven J ^a   Wong, William W ^a   Halyard, Michele Y ^a   Swanson, Scott K ^a   Novicki, Donald E ^a   Ferrigni, Robert G ^a  

^a MAYO CLINIC   (United States)

Author keywords

prostate specific antigen; prostatectomy; prostatic neoplasms; radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE;

EID: 0029960593     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65492-2     Document Type: Article

References (22)

1. Parker, S. L., Tong, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 1996. CA, 65: 5, 1996.
2. Oesterling, J. E., Chan, D. W., Epstein, J. I., Kimball, A. W., Jr., Bruzek, D. J., Rock, R. C., Brendler, C. B. and Walsh, P. C.: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J. Urol., 139: 766, 1988.
3. Ercole, C. J., Lange, P. H., Mathisen, M., Chiou, R. K., Reddy, P. K. and Vessella, R. L.: Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of staging of patients with prostatic cancer. J. Urol., 138: 1181, 1987.
4. Rainwater, L. M., Morgan, W. R., Klee, G. G. and Zincke, H.: Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma. Mayo Clin. Proc., 65: 1118, 1990.
5. Lange, P. H., Ercole, C. J., Lightner, D. J., Fraley, E. E. and Vessella, R.: The value of serum prostate specific antigen determinations before and after radical prostatectomy. J. Urol., 141: 873, 1989.
6. Takayama, T. K., Vessella, R. L., Brawer, M. K., Noteboom, J. and Lange, P. H.: The enhanced detection of persistent disease after prostatectomy with a new prostate specific antigen immunoassay. J. Urol., 150: 374, 1993.
7. Carter, H. B., Partin, A. W., Oesterling, J. E., Weber, J. P., Epstein, J. L, Chan, D. W., Rock, R. C. and Walsh, P. C.: The use of prostate specific antigen in the management of patients with prostate cancer: the Johns Hopkins experience. In: Clinical Aspects of Prostate Cancer. Assessment of New Diagnostic and Management Procedures. Edited by W. J. Catalona, D. S. Coffey and J. P. Karr. New York: Elsevier Science Publishing Co., pp. 247-251, 1989.
8. Morgan, W. R., Zinke, H., Rainwater, L. M., Myers, R. P. and Klee, G. G.: Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation). J. Urol., 145: 319, 1991.
9. Hudson, M. A., Bahnson, R. B. and Catalona, W. J.: Clinical use of prostate specific antigen in patients with prostate cancer, J. Urol., 142: 1011, 1989.
10. Stamey, T. A., Kabalin, J. N., McNeal, J. E., Johnstone, I. M., Freiha, F., Redwine, E. A. and Yang, N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J. Urol., 141: 1076, 1989.
11. Prestigiacomo, A. F. and Stamey, T. A.: A comparison of 4 ultra-sensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J. Urol., 152: 1515, 1994.
12. Schild, S. E., Buskirk, S. J., Robinow, J. S., Tomera, K M., Ferrigni, R. G. and Frick, L. M.: The results of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy. Int. J. Rad. Oncol. Biol. Phys., 23: 141, 1992.
13. Schild, S. E., Wong, W. W., Grado, G. L., Buskirk, S. J., Robinow, J. S., Frick, L. M. and Ferrigni, R. G.: Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin. Proc., 69: 613, 1994.
14. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317: 909, 1987.
15. Lange, P. H., Lightner, D. J., Medini, E., Reddy, P. K. and Vessella, R. L.: The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J. Urol., 144: 927, 1990.
16. Keisch, M. E., Perez, C. A., Grigsby, P. W., Bauer, W. C. and Catalona, W.: Preliminary report on 10 patients treated with radiotherapy after radical prostatectomy for isolated elevation of serum PSA levels. Int. J. Rad. Oncol. Biol. Phys., 19: 1503, 1990.
17. Hudson, M. A. and Catalona, W. J.: Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. J. Urol., 143: 1174, 1990.
18. Link, P., Freiha, F. S. and Stamey, T. A.: Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J. Urol., 145: 532, 1991.
19. Kaplan, I. D. and Bagshaw, M. A.: Serum prostate-specific antigen after post-prostatectomy radiotherapy. Urology, 39: 401, 1992.
20. Wu, J. J., King, S. C., Montana, G. S., McKinstry, C. A. and Anscher, M. S.: The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int. J. Rad. Oncol. Biol. Phys., 32: 317, 1995.
21. Morris, M. M., Dallow, K. C., Zietman, A. L., Althausen, A. F., Henry, N. M., McGovern, F. J. and Shipley, W. U.: Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int. J. Rad. Oncol. Biol. Phys., suppl. 1, 32: 144, abstract, 1995.
22. McCarthy, J. F., Catalona, W. J. and Hudson, M. A.: Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. J. Urol., 151: 1575, 1994.